Quetiapine monotherapy in bipolar I disorder: a 1-year stabilization in a woman having undergone bone marrow transplantation.
Queatiapine has been used in bipolar mania and most recently in bipolar depression with good results; however, its use in maintenance treatment has not been established yet. A case of a woman suffering from bipolar I disorder who underwent bone marrow transplantation twice because of leukaemia is presented. The use of quetiapine as a monotherapy was efficient and safe and proved to be a good treatment in mood stabilization for 1 year.
Michopoulos
Ioannis
I
2nd Department of Psychiatry, Athens University Medical School, Attikon General Hospital, Athens, Greece.
Christodoulou
Christos
C
Dervenoulas
John
J
Soldatos
Costas R
CR
Lykouras
Lefteris
L
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy*; D016026:Bone Marrow Transplantation / Q000523:psychology*; D003987:Dibenzothiazepines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000523:psychology / Q000628:therapy; D008875:Middle Aged; D000069348:Quetiapine Fumarate; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate